Comments
Loading...
ADC Therapeutics (NYSE:ADCT) Stock, Earnings Estimates, EPS, And Revenue
ADC Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 12
EPS Estimate
$-0.380
Quarterly Revenue Estimate
$19.52M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$70.72M
Analyze the earnings history of ADC Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
ADC Therapeutics (ADCT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $-0.28 | $-0.39 | 28.2 % |
| Q2 | 2024-08-06 | $-0.25 | $-0.44 | 43.2 % |
| Q1 | 2024-05-06 | $-0.38 | $-0.56 | 32.1 % |
| Q4 | 2024-03-13 | $-0.97 | $-0.50 | -94.0 % |
ADC Therapeutics (ADCT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $18.46M | $18.46M | 0.02 % |
| Q2 | 2024-08-06 | $17.41M | $18.93M | -8.03 % |
| Q1 | 2024-05-06 | $18.05M | $18.21M | -0.86 % |
| Q4 | 2024-03-13 | $16.79M | $15.33M | 9.52 % |
FAQ
When is ADC Therapeutics (NYSE:ADCT) reporting earnings?
ADC Therapeutics (ADCT) is scheduled to report earnings on May 5, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
What were the latest earnings per share (EPS) for ADC Therapeutics (NYSE:ADCT)?
The Actual EPS was $-0.28, which beat the estimate of $-0.39.
What were ADC Therapeutics’s (NYSE:ADCT) revenues?
The Actual Revenue was $18.5M, which beat the estimate of $18.5M.
Browse earnings estimates, EPS, and revenue on all stocks.